Brief: Galmed Continues To Drive Innovation With Three New US Patents Granted For Aramchol And Its Meglumine Salt

Eocene

11/01/2022 12:51

Jan 11 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED CONTINUES TO DRIVE INNOVATION WITH THREE NEW US
PATENTS
GRANTED FOR ARAMCHOL AND ITS MEGLUMINE SALT

Source text for Eikon:  ID:nPn90Q0pVa 
Further company coverage:  GLMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))